Clairo

Analyst Channel & Market Intelligence (m/f/d)

Hanover, Lower-Saxony, Germany

Not SpecifiedCompensation
Mid-level (3 to 4 years), Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Marketing, Business Administration, Market ResearchIndustries

Requirements

Candidates should possess a Bachelor’s or Master’s degree in Business Administration, Marketing, or a related field, and a minimum of 3-5 years of experience in a similar role. They should demonstrate strong strategic thinking and analytical skills, an innovative mindset, and the ability to simplify complex ideas, along with problem-solving skills and a positive attitude. Excellent communication and presentation skills, a hands-on mentality, and being a self-starter with a 'can-do' attitude are also required. Fluency in English is essential, and knowledge of additional languages is a plus.

Responsibilities

The Analyst Channel & Market Intelligence will build a structured Market Intelligence framework, support Channel Strategy definition by analyzing customer data, and establish a process for Customer Data Collection to identify market opportunities. They will coordinate yearly updates of Market Mapping, implement a monthly Market Intelligence Newsletter, and ensure consistency with EMEA IAM channel strategy. Furthermore, the role involves supporting Market Model definition and improvement, establishing trusted connections with regions and HQ level, and summarizing outcome and key learnings.

Skills

Market Intelligence
Channel Strategy
Customer Data Analysis
Strategic Thinking
Analytical Skills
Communication Skills
Presentation Skills
Problem-Solving
Data Collection
Market Mapping
EMEA
IAM
Market Model

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

Key Metrics

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI